Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in First Episode Untreated Schizophrenia: A Randomized, Open Label, Active Controlled Study

NCT03304457 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences, Bhubaneswar as lead sponsor.

NCT NCT03304457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03304457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in First Episode Untreated Schizophrenia: A Randomized, Open Label, Active Controlled Study
Lead sponsor
All India Institute of Medical Sciences, Bhubaneswar
Phase
Phase 4
Overall status
Completed
Start date
August 25, 2017
Completion date
March 25, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia